US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ostin Technology Group Co., Ltd.

1.85

-0.0100-0.54%

Post-market: 1.75-0.1000-5.41%19:59 EDT

Volume:9.36M

Turnover:22.08M

Market Cap:67.56M

PE:-0.27

High:2.87

Open:2.17

Low:1.80

Close:1.86

Loading ...

Overview Company News Filings

BUZZ-U.S. STOCKS ON THE MOVE-Grocery Outlet, Abbott, General Dynamics

US Equity Futures Fall as Nvidia Warning Weighs on Investor Sentiment

MT Newswires Live

BRIEF-Ostin Technology Group Announces Pricing Of $5 Million Registered Direct Offering

Ostin Technology Prices $5 Million Registered Securities Offering

MT Newswires Live

Ostin Technology Group Announces Pricing of $5.0 Million Registered Direct Offering

THOMSON REUTERS

Ostin Technology Group Announces Pricing of $5.0 million Registered Direct Offering

OS Therapies announces OST-HER2 data

OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans

OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma

OS Therapies provides regulatory update on OST-HER2

OS Therapies Provides Regulatory Update on Rare Pediatric Cancer Immunotherapy Candidate OST-HER2 for Human Osteosarcoma

OS Therapies Awarded OST-HER2 Clinical Trial Data Presentation at MIB Agents FACTOR Osteosarcoma Conference

OS Therapies schedules Scientific Advice Meeting for OST-HER2 in Q3

OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency's (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma

OS Therapies receives patent notice of allowance for OST-HER2

OS Therapies Says It Signed Manufacturing Deal for Lead Candidate OST-HER2

MT Newswires Live

Ostin Technology Group Co Ltd -Approved, Confirmed Appointment of Lai Kui Sen as Co-Chief Executive Officer

THOMSON REUTERS

OS Therapies announces OST-HER2 trial achieves primary endpoint

Ostin Technology Group Achieves Outstanding Sales Results During Singles’ Day and December 12 Shopping Festivals

Ostin Technology Group Announces Participation at CES 2025, Inspiring Greatness with Latest Pintura Products at the Premier Global Technology Trade Show

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OST/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OST","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OST\",,,,,undefined,":{"symbol":"OST","market":"US","secType":"STK","nameCN":"Ostin Technology Group Co., Ltd.","latestPrice":1.85,"timestamp":1744920000000,"preClose":1.86,"halted":0,"volume":9358328,"hourTrading":{"tag":"盘后","latestPrice":1.75,"preClose":1.85,"latestTime":"19:59 EDT","volume":57914,"amount":104145.1232,"timestamp":1744934375357},"delay":0,"floatShares":35753800,"shares":36521000,"eps":-6.73577,"marketStatus":"Closed Good Friday","change":-0.01,"latestTime":"04-17 16:00:00 EDT","open":2.17,"high":2.87,"low":1.8004,"amount":22076510.0577112,"amplitude":0.575054,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-6.73577,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"listingDate":1651032000000,"exchange":"NASDAQ","adjPreClose":1.86,"preHourTrading":{"tag":"盘前","latestPrice":2.19,"preClose":1.86,"latestTime":"09:29 EDT","volume":137124,"amount":284078.72123280005,"timestamp":1744896599887},"postHourTrading":{"tag":"盘后","latestPrice":1.75,"preClose":1.85,"latestTime":"19:59 EDT","volume":57914,"amount":104145.1232,"timestamp":1744934375357},"volumeRatio":0.42038986627746733},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OST\",,,,,undefined,":{"symbol":"OST","floatShares":35753800,"roa":"-11.19%","roe":"-92.74%","lyrEps":-6.73577,"volumeRatio":0.42038986627746733,"shares":36521000,"dividePrice":0,"high":2.87,"amplitude":0.575054,"preClose":1.86,"low":1.8004,"week52Low":0.7801,"pbRate":"13.01","psRate":"2.08","week52High":5.78,"institutionHeld":0,"latestPrice":1.85,"eps":-6.73577,"divideRate":0,"volume":9358328,"delay":0,"ttmEps":-6.73577,"open":2.17,"prevYearClose":2.68,"prevWeekClose":1.06,"prevMonthClose":1.52,"prevQuarterClose":1.52,"fiveDayClose":0.981,"twentyDayClose":1.98,"sixtyDayClose":2.42},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OST\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2528527322","title":"BUZZ-U.S. STOCKS ON THE MOVE-Grocery Outlet, Abbott, General Dynamics","url":"https://stock-news.laohu8.com/highlight/detail?id=2528527322","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528527322?lang=en_us&edition=fundamental","pubTime":"2025-04-17 02:02","pubTimestamp":1744826527,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Grocery Outlet, Abbott, General DynamicsEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsl","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250416:nL6N3QU0QE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LYFT","RGLD","ICAD","CVX","NEM","GO","ABT","MOV","GD","URGN","CLIK","FRGE","03888","ALV","NOVA","OST","DVN","SIVBQ","NVDY","PLD","CALM","NEE","TGL","OMC","UAL","CYD","HTZ","KKR","XOM","FANG","BLUE","NVIW.SI","AREC","JBHT","SNVD.UK","TRV","HWC","MPC","APA","CFG"],"gpt_icon":1},{"id":"2527217561","title":"US Equity Futures Fall as Nvidia Warning Weighs on Investor Sentiment","url":"https://stock-news.laohu8.com/highlight/detail?id=2527217561","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527217561?lang=en_us&edition=fundamental","pubTime":"2025-04-16 21:06","pubTimestamp":1744808771,"startTime":"0","endTime":"0","summary":"US equity futures dropped ahead of Wednesday's opening bell, with futures of technology-heavy Nasdaq Composite leading the losses after sector heavyweight Nvidia (NVDA) revealed an expected $5.5 billi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"3aa75f2fff3a6e554b48e4a30d9f9347","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2360032135.SGD","SG9999015341.SGD","USJW.SI","LU0124676726.USD","QID","DDM","UAL","NVDS","LU2471134796.USD","QLD","SNVD.UK","DOG","LU2413666699.HKD","2NVD.UK","NVDU","NVD3.UK","EQR","LU0029864427.USD","DXD","PSQ","NVDA","TQQQ","NVD2.UK",".DJI","NQmain","TSYW.SI","SDOW","SQQQ",".IXIC","MNQmain","DJX","NVDD","LU1674673691.USD","HK0000320223.HKD","LU0979878070.USD","NVIW.SI","UDOW","NVDY","3NVD.UK","NVDS.UK",".SPX","LU2592432038.USD","SG9999015358.SGD","USAW.SI","OST","BK4500"],"gpt_icon":1},{"id":"2527382476","title":"BRIEF-Ostin Technology Group Announces Pricing Of $5 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2527382476","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527382476?lang=en_us&edition=fundamental","pubTime":"2025-04-16 05:57","pubTimestamp":1744754254,"startTime":"0","endTime":"0","summary":"BRIEF-Ostin Technology Group Announces Pricing Of $5 Million Registered Direct OfferingApril 15 (Reuters) - Ostin Technology Group Co Ltd OST.O:OSTIN TECHNOLOGY GROUP ANNOUNCES PRICING OF $5.0 MILLION","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUABTTGMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OST","BK4148"],"gpt_icon":0},{"id":"2527473592","title":"Ostin Technology Prices $5 Million Registered Securities Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2527473592","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527473592?lang=en_us&edition=fundamental","pubTime":"2025-04-16 05:11","pubTimestamp":1744751477,"startTime":"0","endTime":"0","summary":"Ostin Technology Group  priced a registered offering to sell 9.09 million Class A ordinary shares and related warrants to several investors to raise $5 million.Each share is being sold together with two associated warrants, each to purchase one share, at a combined offering price of $0.55 apiece, the company said Tuesday in a statement.Each warrant has an exercise price of $0.80 and a two-year expiration period.Ostin Technology stock fell 8.8% in after-hours trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4148","OST"],"gpt_icon":0},{"id":"2527742054","title":"Ostin Technology Group Announces Pricing of $5.0 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2527742054","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527742054?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:30","pubTimestamp":1744749001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250415:nTUABTTGMF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4148","OST"],"gpt_icon":0},{"id":"2527998476","title":"Ostin Technology Group Announces Pricing of $5.0 million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2527998476","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527998476?lang=en_us&edition=fundamental","pubTime":"2025-04-16 04:30","pubTimestamp":1744749000,"startTime":"0","endTime":"0","summary":"Nanjing, China, April 15, 2025  -- Ostin Technology Group Co., Ltd.  , a leading supplier of display modules and polarizers based in China, today announced that it has entered into a securities purchase agreement with several investors for the purchase and sale of  9,090,908 Class A ordinary shares , par value $0.001 per share, of the Company; and  Class A Ordinary Share purchase warrants to purchase up to 90,909,080 Class A Ordinary Shares ; and  up to 90,909,080 Class A Ordinary Shares issuable upon exercise of the Warrants. Each Class A Ordinary Share is being sold together with two associated Warrants, each to purchase one Class A Ordinary Share at a combined offering price of $0.55 per Class A Ordinary Share and associated Warrants.The Warrants have an exercise price of $0.8 per Class A Ordinary Share, which will be immediately exercisable after issuance, and will expire two years from the date of issuance. The Warrants may be exercised on an alternative basis after one-month anni","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ostin-technology-group-announces-pricing-203000962.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4148","OST"],"gpt_icon":0},{"id":"2526356878","title":"OS Therapies announces OST-HER2 data","url":"https://stock-news.laohu8.com/highlight/detail?id=2526356878","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526356878?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:52","pubTimestamp":1744285968,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) announced data in the prevention or delay of amputation during the treatment of primary osteosarcoma for OST-HER2 combined pall...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-ost-her2-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-ost-her2-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OSTX","OST","BK4148"],"gpt_icon":0},{"id":"2526550198","title":"OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans","url":"https://stock-news.laohu8.com/highlight/detail?id=2526550198","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526550198?lang=en_us&edition=fundamental","pubTime":"2025-04-10 19:42","pubTimestamp":1744285320,"startTime":"0","endTime":"0","summary":"Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor, delayed pulmonary metastases and prolonged overall survival of greater than 500 days in 5 out of 15 dogs.Data from new publication in the journal \"Molecular Therapy\" show OST-HER2 induces strong innate and cytotoxic immune responses beginning at the 1st dose of 3 dose regimen, that correlate with prevention of metastasis and long-term survival in dogs with resected primary osteosarcoma.Additionally, the Company announced the publication of positive data in the journal \"Molecular Therapy\" entitled \"Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2\" demonstrated the correlation of innate and adaptive immune responses to OST-HER2, with prevention of metastasis and long-term survival benefit when used in the a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/os-therapies-announces-positive-data-114200323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADC","OSTX","BK4195","DC","PFS","BK4211","BK4139","BK4148","OST","BK4080","BK4231","BK4017"],"gpt_icon":1},{"id":"2525018533","title":"OS Therapies Requests Meeting with FDA to Gain Agreement on Surrogate Endpoint(s) for Breakthrough Therapy Designation & Accelerated Approval of OST-HER2 in the Prevention of Recurrence of Fully Resected, Lung Metastatic Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2525018533","media":"Business Wire","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525018533?lang=en_us&edition=fundamental","pubTime":"2025-04-07 18:00","pubTimestamp":1744020000,"startTime":"0","endTime":"0","summary":"OS Therapies applies for meeting per FDA suggestion received on April 2, 2025. Based on prior FDA guidance, greater than 200 suitable matched lung metastatic osteosarcoma patient records identified from leading oncology centers in the US, UK and France for inclusion in OST-400, a Retrospective Longitudinal Study of Recurrent Osteosarcoma after Resection in Children and Young Adults. \"We are excited to meet with the FDA – and commence market access discussions - the goal of receiving Accelerated Approval for a Biologics License Application of OST-HER2 in the prevention or delay of recurrence lung metastatic osteosarcoma by year-end 2025,\" said Dr. Robert Petit, Chief Medical & Scientific Officer of OS Therapies. \"We believe that we have identified the comparator data necessary to address the comments from FDA regarding our prior BTD request. We expect this data will also be able support our application for Accelerated Approval. Our clinical and regulatory teams are diligently preparing ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/os-therapies-requests-meeting-fda-100000983.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OSTX","BK4080","BK4148","BK4139","OS","BK4097","BK4231","OST","BK4017","ADC","DC"],"gpt_icon":0},{"id":"2523945190","title":"OS Therapies provides regulatory update on OST-HER2","url":"https://stock-news.laohu8.com/highlight/detail?id=2523945190","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523945190?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:55","pubTimestamp":1743422120,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) provided a regulatory update for its OST-HER2 listeria monocytogenes immunotherapeutic cancer biologic drug candidate in the pr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-provides-regulatory-update-on-ost-her2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-provides-regulatory-update-on-ost-her2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4148","BK4139","OST","OSTX"],"gpt_icon":0},{"id":"2523456169","title":"OS Therapies Provides Regulatory Update on Rare Pediatric Cancer Immunotherapy Candidate OST-HER2 for Human Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2523456169","media":"Business Wire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523456169?lang=en_us&edition=fundamental","pubTime":"2025-03-31 19:40","pubTimestamp":1743421200,"startTime":"0","endTime":"0","summary":"New canine elite responder biomarkers added to human biomarker strategy. NEW YORK, March 31, 2025----OS Therapies  , a clinical-stage immunotherapy and Antibody Drug Conjugate  biopharmaceutical company, today provided a regulatory update for its OST-HER2 listeria monocytogenes  immunotherapeutic cancer biologic drug candidate in the prevention or delay of fully-resected, recurrent, lung metastatic osteosarcoma.\"We are making rapid progress in putting together an appropriate data package to achieve accelerated approval for OST-HER2 given the feedback we’ve received to date from the FDA,\" said Paul Romness, MHP, Chairman & CEO of OS Therapies. \"We know one of the US government’s stated priorities is to treat deadly childhood cancers, and we believe that OST-HER2 for osteosarcoma aligns well with that mission.\". The Company initiated regulatory correspondence with the US Food & Drug Administration  and the United Kingdom’s Medicines and Healthcare products Regulatory Agency  in the first","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/os-therapies-provides-regulatory-rare-114000177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OS","BK4543","BK4139","DC","NICE","BK4080","BK4148","BK4097","IE00BFMHRM44.USD","OSTX","BK4023","BK4017","BK4566","ADC","OST","BK4231"],"gpt_icon":0},{"id":"2519838093","title":"OS Therapies Awarded OST-HER2 Clinical Trial Data Presentation at MIB Agents FACTOR Osteosarcoma Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2519838093","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2519838093?lang=en_us&edition=fundamental","pubTime":"2025-03-13 19:40","pubTimestamp":1741866000,"startTime":"0","endTime":"0","summary":"NEW YORK, March 13, 2025----OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has been awarded a presentation slot at the MIB Agents Factor Osteosarcoma Conference to be held June 26-28, 2025 in Salt Lake City, Utah. Key data will be presented from the Company’s Phase 2b clinical trial of OST-HER2 in the prevention of recurrent, fully resected, lung metastatic osteosarcoma. This data will be compared with a newly created regulatorily compliant synthetic control group comprised of case matched controls that will be used for the Company’s US Food & Drug Administration  OST-HER2 Biologics License Application  submission. Equivalent submissions with international regulatory authorities will be made in order to gain commercial marketing authorization. MIB Agents FACTOR is the most important annual osteosarcoma conference bringing together the leading osteosarcoma researchers, clini","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/os-therapies-awarded-ost-her2-114000281.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","BK4139","BK4231","OST","BK4148","OS","DC","BK4097","ADC","OSTX","BK4017"],"gpt_icon":0},{"id":"2518748676","title":"OS Therapies schedules Scientific Advice Meeting for OST-HER2 in Q3","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748676","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518748676?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:51","pubTimestamp":1741693876,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) announced that it has scheduled a Scientific Advice Meeting in the third quarter of 2025 to discuss the Innovative Licensing an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-schedules-scientific-advice-meeting-for-ost-her2-in-q3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-schedules-scientific-advice-meeting-for-ost-her2-in-q3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OST","BK4148","OSTX"],"gpt_icon":0},{"id":"2518418748","title":"OS Therapies Schedules United Kingdom’s Medicines and Healthcare products Regulatory Agency's (MHRA) Scientific Advice Meeting in the Third Quarter of 2025 for Review of its OST-HER2 Immunotherapy Candidate for Osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2518418748","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518418748?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:40","pubTimestamp":1741693200,"startTime":"0","endTime":"0","summary":"NEW YORK, March 11, 2025----OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has scheduled a Scientific Advice Meeting  in the third quarter of 2025 to discuss the Innovative Licensing and Access Pathway  with the United Kingdom’s  Medicines and Healthcare products Regulatory Agency  for OST-HER2, its immunotherapy candidate for the prevention of recurrence of metastases in osteosarcoma. The Company released positive Phase 2b data in January 2025 that demonstrates statistically significant results in the primary endpoint of the study, 12-month event free survival . The meeting with MHRA has been scheduled to position the Company to bring OST-HER2 to market in the UK in 2025.\"Today’s announcement marks the beginning of the regulatory process required to bring our OST-HER2 immunotherapy to market globally,\" stated OS Therapies’ CEO Paul Romness. \"As we prepare for regulatory in","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/os-therapies-schedules-united-kingdom-114000512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["UK","BK4585","OST","BK4017","DC","BK4080","BK4588","BK4139","BK4158","UBCP","BK4233","MDCO","BK4528","BK4137","BK4532","ADC","BK4211","SAM","BK4205","BK4148","BK4231","OS","HCSG","OSTX","BK4097"],"gpt_icon":0},{"id":"2512412906","title":"OS Therapies receives patent notice of allowance for OST-HER2","url":"https://stock-news.laohu8.com/highlight/detail?id=2512412906","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512412906?lang=en_us&edition=fundamental","pubTime":"2025-02-20 18:20","pubTimestamp":1740046834,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) announced that it received a notice of allowance from the United States Patent & Trademark Office that a patent will be issued ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-receives-patent-notice-of-allowance-for-ost-her2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-receives-patent-notice-of-allowance-for-ost-her2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4148","OST","BK4139"],"gpt_icon":0},{"id":"2511225695","title":"OS Therapies Says It Signed Manufacturing Deal for Lead Candidate OST-HER2","url":"https://stock-news.laohu8.com/highlight/detail?id=2511225695","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511225695?lang=en_us&edition=fundamental","pubTime":"2025-02-14 22:29","pubTimestamp":1739543355,"startTime":"0","endTime":"0","summary":"OS Therapies  said Friday it has signed agreements to begin commercial manufacturing of its lead asset OST-HER2 as it prepares for a potential Biologics License Application submission to the US Food and Drug Administration.The company said it is compiling additional data from its recently completed phase 2b trial of OST-HER2 for lung metastatic osteosarcoma recurrence prevention.It plans to meet with the FDA for regulatory discussions before submitting a BLA for accelerated or conditional approval, OS Therapies added.Shares of the company were up more than 36% in recent Friday premarket activity.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","OSTX","OST","BK4148"],"gpt_icon":0},{"id":"2505733672","title":"Ostin Technology Group Co Ltd -Approved, Confirmed Appointment of Lai Kui Sen as Co-Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2505733672","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505733672?lang=en_us&edition=fundamental","pubTime":"2025-01-22 06:31","pubTimestamp":1737498675,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250121:nFWN3OH1Y2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4148","OST"],"gpt_icon":0},{"id":"2503648266","title":"OS Therapies announces OST-HER2 trial achieves primary endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2503648266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503648266?lang=en_us&edition=fundamental","pubTime":"2025-01-15 20:45","pubTimestamp":1736945112,"startTime":"0","endTime":"0","summary":"OS Therapies (OSTX) announced data from a Phase 2b clinical trial of OST-HER2 – the company’s HER2-targeted immunotherapy candidate in the rare ped...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-ost-her2-trial-achieves-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-announces-ost-her2-trial-achieves-primary-endpoint?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OST","BK4139","OSTX","BK4148"],"gpt_icon":0},{"id":"2501727158","title":"Ostin Technology Group Achieves Outstanding Sales Results During Singles’ Day and December 12 Shopping Festivals","url":"https://stock-news.laohu8.com/highlight/detail?id=2501727158","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501727158?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:30","pubTimestamp":1736343000,"startTime":"0","endTime":"0","summary":"Nanjing, China, Jan. 08, 2025  -- Ostin Technology Group Co., Ltd.  , a supplier of display modules and polarizers in China, today announced that its digital photo frame and display product, Pintura, has achieved remarkable sales during the recently concluded “Singles’ Day” and “December 12” shopping festivals. Pintura excelled on various domestic e-commerce platforms, ranking second in the category of digital photo frame sales on Tmall and Taobao, and third on JD.com and Douyin during the Singles’ Day shopping festival. Pintura’s online store also ranked among the top two digital frame sellers during the December 12 shopping festival on Taobao and Tmall. These results highlight the growing popularity of the Pintura brand and the strong recognition that consumers have for the Pintura brand.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ostin-technology-group-achieves-outstanding-133000431.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OST"],"gpt_icon":0},{"id":"2500411929","title":"Ostin Technology Group Announces Participation at CES 2025, Inspiring Greatness with Latest Pintura Products at the Premier Global Technology Trade Show","url":"https://stock-news.laohu8.com/highlight/detail?id=2500411929","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500411929?lang=en_us&edition=fundamental","pubTime":"2025-01-02 21:30","pubTimestamp":1735824600,"startTime":"0","endTime":"0","summary":"Nanjing, China, Jan. 02, 2025  -- Ostin Technology Group Co., Ltd.  , a supplier of display modules and polarizers in China, today announces the Company will participate in the Consumer Electronics Show 2025 , one of the world’s premier technology trade shows. CES 2025 is scheduled to take place from January 7 to 10, 2025, at the Las Vegas Convention Center in Las Vegas, NV., which allows the Company to meet new partners, and it is also where the industry’s sharpest minds take the stage to unveil their latest releases and boldest breakthroughs. Visitors can find the Company’s CES 2025 booth at booth 22015, Central Hall in Las Vegas Convention Center.As a company committed to pushing the boundaries of technology and driving industry advancements, the Company looks forward to engaging with the brightest minds in the industry and the most impactful brands. The Company expects to exhibit its latest line of wireless photo transmission products, the Pintura products, while looking to connect","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ostin-technology-group-announces-participation-133000645.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ostin Technology Group Announces Participation at CES 2025, Inspiring Greatness with Latest Pintura Products at the Premier Global Technology Trade Show","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["OST","BK4148"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":32,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OST\",params:#limit:5,,,undefined,":[{"market":"US","date":"2024-12-31","symbol":"OST","defaultRemindTime":1735655400000,"type":"split","dateTimestamp":1735621200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2023-02-16","symbol":"OST","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1676523600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2022-08-19","symbol":"OST","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1660881600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OST\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OST\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OST\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OST","date":"2025-04-17","current":-0.38481,"percent":0.508287,"low":-2.40837,"twenty":-0.729378,"median":-0.401122,"eighty":9.636189,"high":129.57886,"avg":12.574768,"sd":25.239108,"marketCap":3871805},"quantilePoints":[{"date":"2022-04-29","current":12.088799,"twenty":14.441214,"median":17.425296,"eighty":39.856009,"marketCap":37462500},{"date":"2022-05-06","current":13.199662,"twenty":12.350179,"median":14.702593,"eighty":17.425296,"marketCap":40905000},{"date":"2022-05-13","current":10.716557,"twenty":10.54666,"median":12.415524,"eighty":15.900583,"marketCap":33210000},{"date":"2022-05-20","current":9.496786,"twenty":10.058752,"median":11.345828,"eighty":15.127335,"marketCap":29430000},{"date":"2022-05-27","current":9.235407,"twenty":9.374809,"median":10.716557,"eighty":14.506559,"marketCap":28620000},{"date":"2022-06-03","current":8.712648,"twenty":8.956602,"median":10.172017,"eighty":13.670145,"marketCap":27000000},{"date":"2022-06-10","current":8.146326,"twenty":8.8172,"median":9.769057,"eighty":12.729179,"marketCap":25245000},{"date":"2022-06-17","current":8.0592,"twenty":8.425131,"median":9.40966,"eighty":12.219489,"marketCap":24975000},{"date":"2022-06-24","current":8.233453,"twenty":8.233453,"median":9.104717,"eighty":11.818707,"marketCap":25515000},{"date":"2022-07-01","current":7.492877,"twenty":8.0592,"median":8.99581,"eighty":11.359376,"marketCap":23220000},{"date":"2022-07-08","current":7.580004,"twenty":7.902372,"median":8.908683,"eighty":11.218057,"marketCap":23490000},{"date":"2022-07-15","current":7.144371,"twenty":7.580004,"median":8.712648,"eighty":10.925661,"marketCap":22140000},{"date":"2022-07-22","current":7.057245,"twenty":7.475452,"median":8.516614,"eighty":10.612005,"marketCap":21870000},{"date":"2022-07-29","current":7.231498,"twenty":7.318624,"median":8.233453,"eighty":10.189442,"marketCap":22410000},{"date":"2022-08-05","current":9.366097,"twenty":7.344762,"median":8.407706,"eighty":10.612005,"marketCap":29025000},{"date":"2022-08-12","current":9.714603,"twenty":7.449314,"median":8.581958,"eighty":10.612005,"marketCap":30105000},{"date":"2022-08-19","current":10.733997,"twenty":7.45367,"median":8.799774,"eighty":10.620718,"marketCap":30792500},{"date":"2022-08-26","current":9.024157,"twenty":7.475452,"median":8.930464,"eighty":10.228649,"marketCap":25887500},{"date":"2022-09-02","current":8.192985,"twenty":7.492877,"median":8.908683,"eighty":10.193798,"marketCap":23503125},{"date":"2022-09-09","current":8.216732,"twenty":7.492877,"median":8.884286,"eighty":10.193798,"marketCap":23571250},{"date":"2022-09-16","current":6.934352,"twenty":7.449314,"median":8.60374,"eighty":10.172017,"marketCap":19892500},{"date":"2022-09-23","current":5.88945,"twenty":7.318624,"median":8.516614,"eighty":10.164051,"marketCap":16895000},{"date":"2022-09-30","current":5.46199,"twenty":7.275061,"median":8.264228,"eighty":10.150235,"marketCap":15668750},{"date":"2022-10-07","current":5.556981,"twenty":7.144371,"median":8.225093,"eighty":10.106672,"marketCap":15941250},{"date":"2022-10-14","current":4.844547,"twenty":6.970119,"median":8.169237,"eighty":9.975982,"marketCap":13897500},{"date":"2022-10-21","current":4.537726,"twenty":6.882992,"median":8.157217,"eighty":9.867074,"marketCap":13017325},{"date":"2022-10-28","current":5.058277,"twenty":6.126928,"median":8.0592,"eighty":9.845292,"marketCap":14510625},{"date":"2022-11-04","current":5.129521,"twenty":5.88945,"median":8.019227,"eighty":9.714603,"marketCap":14715000},{"date":"2022-11-11","current":5.319503,"twenty":5.556981,"median":7.884947,"eighty":9.671039,"marketCap":15260000},{"date":"2022-11-18","current":5.794459,"twenty":5.604476,"median":7.623567,"eighty":9.627476,"marketCap":16622500},{"date":"2022-11-25","current":5.528484,"twenty":5.551282,"median":7.580004,"eighty":9.592626,"marketCap":15859500},{"date":"2022-12-02","current":4.939539,"twenty":5.452491,"median":7.492877,"eighty":9.554069,"marketCap":14170000},{"date":"2022-12-09","current":4.892043,"twenty":5.300505,"median":7.460205,"eighty":9.50675,"marketCap":14033750},{"date":"2022-12-16","current":4.557199,"twenty":5.129521,"median":7.318624,"eighty":9.427085,"marketCap":13073187},{"date":"2022-12-23","current":3.881812,"twenty":5.077275,"median":7.318624,"eighty":9.37481,"marketCap":11135712},{"date":"2022-12-30","current":4.488331,"twenty":4.987034,"median":7.294689,"eighty":9.360414,"marketCap":12875625},{"date":"2023-01-06","current":4.939539,"twenty":4.939539,"median":7.270941,"eighty":9.31863,"marketCap":14170000},{"date":"2023-01-13","current":5.082025,"twenty":4.939539,"median":7.144371,"eighty":9.251144,"marketCap":14578750},{"date":"2023-01-20","current":5.628224,"twenty":4.939539,"median":7.057245,"eighty":9.221654,"marketCap":16145625},{"date":"2023-01-27","current":5.272008,"twenty":4.939539,"median":6.975983,"eighty":9.157145,"marketCap":15123750},{"date":"2023-02-03","current":5.177016,"twenty":4.939539,"median":6.926555,"eighty":9.116262,"marketCap":14851250},{"date":"2023-02-10","current":5.176541,"twenty":4.939539,"median":6.766185,"eighty":9.096004,"marketCap":14849887},{"date":"2023-02-17","current":72.502674,"twenty":4.943244,"median":6.649379,"eighty":9.116262,"marketCap":14426437},{"date":"2023-02-24","current":72.256305,"twenty":4.958062,"median":6.926555,"eighty":9.261635,"marketCap":14377415},{"date":"2023-03-03","current":70.390948,"twenty":4.977535,"median":6.952236,"eighty":9.496786,"marketCap":14006250},{"date":"2023-03-10","current":69.335082,"twenty":4.987034,"median":7.057245,"eighty":9.671039,"marketCap":13796156},{"date":"2023-03-17","current":50.04796,"twenty":4.987034,"median":7.144371,"eighty":9.975982,"marketCap":9958443},{"date":"2023-03-24","current":54.904939,"twenty":5.047353,"median":7.266821,"eighty":10.172017,"marketCap":10924875},{"date":"2023-03-31","current":64.689277,"twenty":5.058277,"median":7.294689,"eighty":10.716557,"marketCap":12871743},{"date":"2023-04-06","current":65.548051,"twenty":5.077275,"median":7.318624,"eighty":11.037967,"marketCap":13042620},{"date":"2023-04-14","current":62.127049,"twenty":5.082025,"median":7.318624,"eighty":12.110581,"marketCap":12361916},{"date":"2023-04-21","current":59.832233,"twenty":5.082025,"median":7.460205,"eighty":14.506559,"marketCap":11905298},{"date":"2023-04-28","current":62.42269,"twenty":5.082025,"median":7.492877,"eighty":23.949829,"marketCap":12420742},{"date":"2023-05-05","current":81.653499,"twenty":5.082025,"median":7.580004,"eighty":54.973922,"marketCap":16247250},{"date":"2023-05-12","current":83.061318,"twenty":5.101023,"median":7.66713,"eighty":55.955168,"marketCap":16527375},{"date":"2023-05-19","current":83.061318,"twenty":5.124771,"median":7.92851,"eighty":59.222717,"marketCap":16527375},{"date":"2023-05-26","current":76.726131,"twenty":5.129521,"median":8.0592,"eighty":60.029398,"marketCap":15266812},{"date":"2023-06-02","current":71.094855,"twenty":5.129521,"median":8.0592,"eighty":61.586405,"marketCap":14146312},{"date":"2023-06-09","current":72.502674,"twenty":5.157733,"median":8.157217,"eighty":62.729596,"marketCap":14426437},{"date":"2023-06-16","current":75.670265,"twenty":5.176541,"median":8.169237,"eighty":64.131782,"marketCap":15056718},{"date":"2023-06-23","current":71.932505,"twenty":5.176731,"median":8.216732,"eighty":64.727247,"marketCap":14312986},{"date":"2023-06-30","current":59.832303,"twenty":5.177016,"median":8.233453,"eighty":64.739904,"marketCap":11905312},{"date":"2023-07-07","current":61.254199,"twenty":5.177016,"median":8.320579,"eighty":64.752561,"marketCap":12188238},{"date":"2023-07-14","current":65.456538,"twenty":5.177016,"median":8.560177,"eighty":65.548051,"marketCap":13024411},{"date":"2023-07-21","current":65.815532,"twenty":5.211213,"median":8.712648,"eighty":65.993693,"marketCap":13095843},{"date":"2023-07-28","current":61.240122,"twenty":5.224512,"median":8.886901,"eighty":66.420896,"marketCap":12185437},{"date":"2023-08-04","current":58.424484,"twenty":5.224512,"median":8.974028,"eighty":66.167491,"marketCap":11625187},{"date":"2023-08-11","current":-1.805108,"twenty":5.177016,"median":8.886901,"eighty":66.167491,"marketCap":10812825},{"date":"2023-08-18","current":-1.469573,"twenty":5.129521,"median":8.712648,"eighty":65.993693,"marketCap":8802928},{"date":"2023-08-25","current":-1.870579,"twenty":5.082025,"median":8.560177,"eighty":65.815532,"marketCap":11205000},{"date":"2023-09-01","current":-2.010872,"twenty":5.082025,"median":8.320579,"eighty":65.548051,"marketCap":12045375},{"date":"2023-09-08","current":-1.56661,"twenty":4.987034,"median":8.233453,"eighty":65.480473,"marketCap":9384187},{"date":"2023-09-15","current":-2.059325,"twenty":4.939539,"median":8.204859,"eighty":65.457946,"marketCap":12335612},{"date":"2023-09-22","current":-1.613374,"twenty":4.939539,"median":8.169237,"eighty":64.893356,"marketCap":9664312},{"date":"2023-09-29","current":-1.706903,"twenty":4.934599,"median":8.134034,"eighty":64.73009,"marketCap":10224562},{"date":"2023-10-06","current":-2.222247,"twenty":4.892043,"median":8.0592,"eighty":64.718843,"marketCap":13311540},{"date":"2023-10-13","current":-1.77705,"twenty":4.844547,"median":7.975664,"eighty":64.694909,"marketCap":10644750},{"date":"2023-10-20","current":-1.707371,"twenty":4.842837,"median":7.79782,"eighty":64.689277,"marketCap":10227363},{"date":"2023-10-27","current":-1.821476,"twenty":4.805221,"median":7.66713,"eighty":64.600585,"marketCap":10910868},{"date":"2023-11-03","current":-1.891155,"twenty":4.681163,"median":7.580004,"eighty":64.207805,"marketCap":11328255},{"date":"2023-11-10","current":-1.94774,"twenty":4.557674,"median":7.492877,"eighty":64.054338,"marketCap":11667206},{"date":"2023-11-17","current":-2.40837,"twenty":4.512079,"median":7.460205,"eighty":64.035993,"marketCap":14426437},{"date":"2023-11-24","current":-2.221312,"twenty":4.488331,"median":7.383969,"eighty":63.98537,"marketCap":13305937},{"date":"2023-12-01","current":-2.279768,"twenty":3.881812,"median":7.318624,"eighty":63.344812,"marketCap":13656093},{"date":"2023-12-08","current":-2.19793,"twenty":-1.541357,"median":7.294689,"eighty":62.957664,"marketCap":13165875},{"date":"2023-12-15","current":-1.800432,"twenty":-1.613374,"median":7.266821,"eighty":62.577551,"marketCap":10784812},{"date":"2023-12-22","current":-1.882503,"twenty":-1.629975,"median":7.144371,"eighty":62.42269,"marketCap":11276431},{"date":"2023-12-29","current":-1.870579,"twenty":-1.64017,"median":7.057245,"eighty":62.355114,"marketCap":11205000},{"date":"2024-01-05","current":-1.84696,"twenty":-1.688011,"median":7.019547,"eighty":62.279092,"marketCap":11063522},{"date":"2024-01-12","current":-1.823814,"twenty":-1.706903,"median":6.934352,"eighty":62.149572,"marketCap":10924875},{"date":"2024-01-19","current":-1.589994,"twenty":-1.706903,"median":6.926555,"eighty":62.127049,"marketCap":9524264},{"date":"2024-01-26","current":-1.402698,"twenty":-1.706903,"median":6.601883,"eighty":61.254199,"marketCap":8402335},{"date":"2024-02-02","current":-1.367861,"twenty":-1.706903,"median":6.126928,"eighty":61.240122,"marketCap":8193656},{"date":"2024-02-09","current":-0.683887,"twenty":-1.706903,"median":5.936946,"eighty":61.225975,"marketCap":7487741},{"date":"2024-02-16","current":-0.741837,"twenty":-1.695212,"median":5.88945,"eighty":61.225975,"marketCap":8122224},{"date":"2024-02-23","current":-0.777912,"twenty":-1.690349,"median":5.841954,"eighty":61.158453,"marketCap":8517200},{"date":"2024-03-01","current":-0.658942,"twenty":-1.684643,"median":5.794459,"eighty":60.882538,"marketCap":7214619},{"date":"2024-03-08","current":-0.639625,"twenty":-1.652656,"median":5.699468,"eighty":60.327855,"marketCap":7003125},{"date":"2024-03-15","current":-0.639626,"twenty":-1.63858,"median":5.640098,"eighty":59.915364,"marketCap":7003139},{"date":"2024-03-22","current":-0.785913,"twenty":-1.636803,"median":5.604476,"eighty":59.834415,"marketCap":8604800},{"date":"2024-03-28","current":-0.769642,"twenty":-1.636756,"median":5.556981,"eighty":59.832303,"marketCap":8426653},{"date":"2024-04-05","current":-0.716225,"twenty":-1.632687,"median":5.509485,"eighty":59.832303,"marketCap":7841796},{"date":"2024-04-12","current":-0.730346,"twenty":-1.627029,"median":5.414494,"eighty":59.832303,"marketCap":7996413},{"date":"2024-04-19","current":-0.781308,"twenty":-1.618191,"median":5.414494,"eighty":59.832261,"marketCap":8554381},{"date":"2024-04-26","current":-0.626735,"twenty":-1.613468,"median":5.366999,"eighty":59.82805,"marketCap":6861991},{"date":"2024-05-03","current":-0.660198,"twenty":-1.613374,"median":5.319503,"eighty":59.622536,"marketCap":7228368},{"date":"2024-05-10","current":-0.646334,"twenty":-1.606359,"median":5.272008,"eighty":59.288884,"marketCap":7076574},{"date":"2024-05-17","current":-0.642545,"twenty":-1.594809,"median":5.224512,"eighty":58.71731,"marketCap":7035096},{"date":"2024-05-24","current":-0.644694,"twenty":-1.590087,"median":5.177016,"eighty":58.424484,"marketCap":7058625},{"date":"2024-05-31","current":-0.629344,"twenty":-1.589993,"median":5.177016,"eighty":58.340014,"marketCap":6890562},{"date":"2024-06-07","current":-0.614301,"twenty":-1.589992,"median":5.153031,"eighty":58.024662,"marketCap":6725861},{"date":"2024-06-14","current":-0.765498,"twenty":-1.585316,"median":5.129521,"eighty":57.736059,"marketCap":8381276},{"date":"2024-06-21","current":-0.659891,"twenty":-1.56661,"median":5.093899,"eighty":57.713536,"marketCap":7225006},{"date":"2024-06-28","current":-0.660044,"twenty":-1.56661,"median":5.082025,"eighty":57.575569,"marketCap":7226687},{"date":"2024-07-05","current":-0.595575,"twenty":-1.561559,"median":5.082025,"eighty":57.015256,"marketCap":6520825},{"date":"2024-07-12","current":-0.570247,"twenty":-1.538551,"median":5.058277,"eighty":55.589135,"marketCap":6243521},{"date":"2024-07-15","current":-0.582527,"twenty":-1.535745,"median":5.052815,"eighty":55.576466,"marketCap":6377971},{"date":"2024-08-02","current":-0.478762,"twenty":-1.532939,"median":5.047353,"eighty":55.563796,"marketCap":5241869},{"date":"2024-08-09","current":-0.417823,"twenty":-1.508949,"median":4.982285,"eighty":55.399883,"marketCap":4574661},{"date":"2024-08-16","current":-0.514374,"twenty":-1.496557,"median":4.939539,"eighty":55.272912,"marketCap":5631774},{"date":"2024-08-23","current":-0.537399,"twenty":-1.480329,"median":4.939539,"eighty":55.042904,"marketCap":5883868},{"date":"2024-08-30","current":-0.491466,"twenty":-1.429448,"median":4.939539,"eighty":54.140491,"marketCap":5209937},{"date":"2024-09-06","current":-0.4921,"twenty":-1.388763,"median":4.939539,"eighty":53.577363,"marketCap":5216660},{"date":"2024-09-13","current":-0.482745,"twenty":-1.260489,"median":4.903442,"eighty":52.117456,"marketCap":5117486},{"date":"2024-09-20","current":-0.493527,"twenty":-1.056222,"median":4.892043,"eighty":36.998894,"marketCap":5231785},{"date":"2024-09-27","current":-0.520795,"twenty":-0.970924,"median":4.891568,"eighty":17.425296,"marketCap":5520853},{"date":"2024-10-04","current":-0.602442,"twenty":-0.939264,"median":4.844547,"eighty":16.66294,"marketCap":6386375},{"date":"2024-10-11","current":-0.554881,"twenty":-0.908728,"median":4.844309,"eighty":15.32337,"marketCap":5882187},{"date":"2024-10-18","current":-0.651588,"twenty":-0.834917,"median":4.797052,"eighty":14.767938,"marketCap":6907368},{"date":"2024-10-25","current":-0.515246,"twenty":-0.788215,"median":4.697074,"eighty":13.905386,"marketCap":5462031},{"date":"2024-10-31","current":-0.681711,"twenty":-0.784992,"median":4.666201,"eighty":13.042834,"marketCap":7226687},{"date":"2024-11-08","current":-0.438514,"twenty":-0.780629,"median":4.559574,"eighty":12.371961,"marketCap":4648608},{"date":"2024-11-15","current":-0.396343,"twenty":-0.776837,"median":4.524902,"eighty":12.175925,"marketCap":4201562},{"date":"2024-11-22","current":-0.413645,"twenty":-0.77196,"median":4.512079,"eighty":12.067017,"marketCap":4384972},{"date":"2024-11-29","current":-0.448938,"twenty":-0.769642,"median":4.512079,"eighty":11.979891,"marketCap":4759103},{"date":"2024-12-06","current":-0.417629,"twenty":-0.768261,"median":4.297873,"eighty":11.413569,"marketCap":4427212},{"date":"2024-12-13","current":-0.322757,"twenty":-0.767493,"median":3.881812,"eighty":11.278087,"marketCap":3421485},{"date":"2024-12-20","current":-0.337177,"twenty":-0.767493,"median":-0.32807,"eighty":10.977937,"marketCap":3574355},{"date":"2024-12-27","current":-0.379491,"twenty":-0.767493,"median":-0.32807,"eighty":10.803683,"marketCap":4022910},{"date":"2025-01-03","current":-0.438312,"twenty":-0.767493,"median":-0.333668,"eighty":10.744446,"marketCap":4646461},{"date":"2025-01-10","current":-0.461081,"twenty":-0.767493,"median":-0.336638,"eighty":10.727021,"marketCap":4887835},{"date":"2025-01-17","current":-0.459184,"twenty":-0.767493,"median":-0.337747,"eighty":10.524879,"marketCap":4867721},{"date":"2025-01-24","current":-0.459184,"twenty":-0.767493,"median":-0.351219,"eighty":10.228649,"marketCap":4867721},{"date":"2025-01-31","current":-0.531699,"twenty":-0.767094,"median":-0.375479,"eighty":10.193798,"marketCap":5349753},{"date":"2025-02-07","current":-0.558595,"twenty":-0.764545,"median":-0.393152,"eighty":10.189442,"marketCap":5620363},{"date":"2025-02-14","current":-0.535837,"twenty":-0.759017,"median":-0.397404,"eighty":10.170424,"marketCap":5391385},{"date":"2025-02-21","current":-0.554457,"twenty":-0.752143,"median":-0.407384,"eighty":10.164051,"marketCap":5578730},{"date":"2025-02-28","current":-0.519286,"twenty":-0.752143,"median":-0.415542,"eighty":10.150235,"marketCap":5224856},{"date":"2025-03-07","current":-0.504804,"twenty":-0.75199,"median":-0.416681,"eighty":10.106672,"marketCap":5079143},{"date":"2025-03-14","current":-0.471702,"twenty":-0.747082,"median":-0.417629,"eighty":9.975982,"marketCap":4746084},{"date":"2025-03-21","current":-0.409636,"twenty":-0.741837,"median":-0.41725,"eighty":9.867074,"marketCap":4121599},{"date":"2025-03-28","current":-0.349639,"twenty":-0.738482,"median":-0.415542,"eighty":9.845292,"marketCap":3517931},{"date":"2025-04-04","current":-0.299779,"twenty":-0.730346,"median":-0.41411,"eighty":9.714603,"marketCap":3016261},{"date":"2025-04-11","current":-0.202956,"twenty":-0.730196,"median":-0.409636,"eighty":9.671039,"marketCap":2042065},{"date":"2025-04-17","current":-0.38481,"twenty":-0.729378,"median":-0.401122,"eighty":9.636189,"marketCap":3871805}],"updateTime":1745021007966}}}